Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats.
about
A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer.Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS and Comparison with Other Ethnic Populations
P2860
Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pharmacokinetics and tolerabil ...... inical study in mice and rats.
@en
type
label
Pharmacokinetics and tolerabil ...... inical study in mice and rats.
@en
prefLabel
Pharmacokinetics and tolerabil ...... inical study in mice and rats.
@en
P2093
P2860
P356
P1433
P1476
Pharmacokinetics and tolerabil ...... inical study in mice and rats.
@en
P2093
Edwin Choy
Francis J Hornicek
Henry J Mankin
Jacson K Shen
Zhan Zhang
Zhenfeng Duan
P2860
P2888
P356
10.1038/SREP25659
P407
P577
2016-05-09T00:00:00Z